|
||||||||||||||||||||||
Advertise with PharmaNews.eu
Alternatively, you might target PharmaNews.eu for advertising through your Google AdWords account, and let Google keep track of click-throughs, and budget your daily allotments...
Explore All PharmaNews.eu RSS Channels
RSS is a simple way for you to keep up to date with our latest news. Instead of looking around various web sites manually, you can use the RSS service
 European Commission Issues Positive Decision for Approval of Seroquel XRAstraZeneca announced that the European Commission (EC) has issued a positive decision for the approval of onc... |
 Data from Mipomersen Phase 3 Trial in heFH Patients Presented at ESCGenzyme Corp. (NASDAQ: GENZ) and Isis Pharmaceuticals Inc. (NASDAQ: ISIS) announced that data from the phase 3... |
 Global market launch of Daxas® (Roflumilast) kicks off in GermanyStefan Brinkmann, Managing Director of Nycomed GmbH, kicked off the German market launch of Daxas® (Roflumila... |
 A new era for patients with atrial fibrillation - Dabigatran etexilate at the forefrontThe European Society of Cardiology (ESC) issued revised practice guidelines for the management of atrial fibri... |
|
More in: Pfizer, GlaxoSmithKline, Bayer, AstraZeneca, Novo Nordisk, Novartis, Roche, Sanofi-aventis, Boehringer Ingelheim, Merck KGaA, Abbott, Nycomed, Schering-Plough, Merck, Genzyme, Lilly, Bristol-Myers Squibb, Shire, Amgen |
|
Research & Development
Change in environment sparks stem cell cross-overEU-funded scientists have discovered that stem cells from one of the immune system's main organs can be reprogrammed to form... |
EMIS Acquires Majority Stake in Pharmacy Software Company Rx Systems LimitedEMIS Group plc (AIM: EMIS), the UK's leading supplier of healthcare software to GPs, today announces that it has acquired... |
Pharmacy's online service helps care homes improve their support for residentsPharmacy Plus launched its new Online Service, the service which is freely available to all its customers offers a unique... |
Data on Electronic Sampling, Online Promotion, Tech-Enabled Reps, Customer Service, and iPadsPharmaceutical and healthcare market research company Manhattan Research releases the tenth version of ePharma Physician®, its study focused on physicians... |
|
More in: Research & Development |
|
Sponsored Links
Diabetes PubMed
Latest Diabetes Research News and PubMed facts...
www.diabetespubmed.com
Latest Diabetes Research News and PubMed facts...
www.diabetespubmed.com
Global E-Health Forum 2010
25-26 October 2010, Hamburg, Germany.
www.global-ehealth-forum.com
Who's Online
We have 88 guests online
Conferences & Events
Starting signal sounded: analytica 2012 to offer Early Bird discountThe starting signal has sounded for analytica 2012 in Munich. Application forms for the 23rd International Trade Fair for Laboratory Technology, Analysis and Biotechnology are available to interested companies. Also,... |
Global E-Health Forum to Present Strategies, Solutions and Services for Sustainable Healthcare Delivery25 - 26 October 2010, Hamburg, Germany. Healthcare systems all over the world are facing very similar challenges: demographic shifts, the impact of globalization and an increased burden of chronic... |
Pharma Marketing 2010 - Frankfurt30 September 2010, Frankfurt, Germany. Pharma Marketing 2010 in Frankfurt provides a key platform for Europe's pharmaceutical industry stakeholders, such as yourself, to discover how best to tackle the key... |
CEE Pharmaceutical Markets 201023rd September 2010, Warsaw, Poland. The pharmaceutical industry is one of the most dynamic branches of the economy and ranks among the top ten industrial sectors. Whilst many countries have... |
Clinical Trials 2010 - Frankfurt29 - 30 September 2010, Frankfurt, Germany. In the current environment where minimising cost and delivering ROI are critical themes within the pharma industry, improving your clinical trial infrastructure can... |
|
More in: Conferences & Events |
EC Pharmaceuticals
Awareness of the consequences of antibiotics overuse in the EU On 9 April the European Commission published two reports demonstrating the need for further progress in the European Union on the issue of anti microbial resistance. The first is a... |
EC tops a billion Euros invested in the fight against AIDSNot too far from World AIDS Day, the European Commission can announce that it has invested over one billion Euros in the fight against AIDS, Tuberculosis and Malaria. As a... |
European Commission tops a billion Euros invested in the fight against the global AIDS epidemicThe European Commission has invested over one billion Euros in the fight against AIDS, Tuberculosis and Malaria. As a founding member of the Global Fund to Fight AIDS, Tuberculosis and... |
European Partnership for Action against CancerAt the end of September month, in Brussels, over 300 cancer organisations, patients and cancer survivors, health professionals, researchers, health authorities and health ministers gather to mark the official launch... |
Commission calls on EU Member States to join forces against Alzheimer's diseaseOn 22 July the European Commission called on EU Member States to pool their resources and better coordinate research efforts to combat Alzheimer's and other neurodegenerative diseases. The proposals adopted... |
|
More in: European Commission
|
EMA News
European Medicines Agency starts review of Pandemrix The European Medicines Agency has launched a review of Pandemrix on the request of the European Commission to investigate whether there is a link between cases of narcolepsy and vaccination... |
EMA and US FDA seek potential candidate companies for joint GMP inspection programmeThe European Medicines Agency (EMA) and the Food and Drug Administration of the United States of America (US FDA) continue to seek potential candidate companies for a joint GMP inspection... |
European Medicines Agency update on ongoing benefit-risk review of Avandia, Avandamet and AvaglimThe European Medicines Agency is currently reviewing rosiglitazone to determine the impact of new data from recent publications on the risk of cardiovascular problems on the benefit- risk profile of... |
European Medicines Agency launches new websiteThe European Medicines Agency (EMA) unveiled its new corporate website, the site has been completely redesigned and rebuilt to optimize usability for the Agency's key online audiences and build on... |
|
More in: EMA |
Industry News
Abbott | Amgen | AstraZeneca | Bayer | Boehringer Ingelheim | Bristol-Myers Squibb | Genzyme | GlaxoSmithKline | Lilly | Merck | Merck KGaA | Novartis | Novo Nordisk | Nycomed | Pfizer | Roche | Sanofi-aventis | Schering-Plough | Shire | ...Submit News
